BlackRock Investment Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
BFA
BIT
BlackRock Investment Management's BLUE Position: Q4 2016 in Review
BlackRock Investment Management increased its bluebird bio (BLUE) stake by 2.4% in Q4 2016, buying an estimated $227K and bringing the position to 12,185 shares worth $9.74M. The position accounts for 0.01% of the portfolio, ranked #1131.
BlackRock Investment Management first reported a position in BLUE in Q3 2013 and has held it in 14 quarters since. The position peaked at $10.4M in Q3 2016. 199 funds tracked by Wall St. Rank hold BLUE as of Q4 2016.
- BlackRock Investment Management held 12,185 shares of bluebird bio worth $9.74M as of Q4 2016.
- BlackRock Investment Management bought 286 bluebird bio shares in Q4 2016, an estimated $227K.
- bluebird bio made up 0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1131 holding.
- BlackRock Investment Management first reported a position in bluebird bio in Q3 2013 and has held it in 14 quarters since.
- BlackRock Investment Management's bluebird bio position peaked at $10.4M in Q3 2016.
- 199 funds tracked by Wall St. Rank held bluebird bio as of Q4 2016.
Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.